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Bottom-up synthesis of flat, disc-shaped mesoporous silica nanoparticles, Nanodiscs (NDs), 
and their delivery applications are reported. The NDs can be readily internalized by cells or 
assembled in ordered monolayers, promptly releasing their payload both once internalized or in 
contact with cells adhering to their flat surface. The initial biological investigations underscore the 
potential these particles hold for intracellular and surface-mediated delivery applications, 
representing a significant addition to the biomedical MSNs toolbox. 
Abstract: The role played by the shape of mesoporous silica nanoparticles has been investigated for 
intra- and extracellular delivery. Specifically, we have developed the bottom-up synthesis of flat 
disc-shaped mesoporous silica nanoparticles, the Nanodiscs (NDs). Due to their peculiar shape and 
large porous system, NDs present a higher cellular uptake than commonly investigated spherical 
mesoporous nanoparticles. Moreover, NDs are able to efficiently perform exhaustive delivery of 
their therapeutic cargo when loaded with the anticancer drug Doxorubicin and administered in vitro 
to cancerous HeLa cells. Thanks to their aspect ratio, NDs can also be readily assembled into well-
organized monolayers to be employed in HeLa cells adhesion experiments upon preliminary 
functionalization with a specific targeting ligand. In these conditions NDs are able to deliver a 
hydrophobic dye to adhered cells via the highly accessible vertically aligned pores and their flat 
surface that ensures optimal cell contact. This initial investigation on the performance of NDs in 




Mesoporous silica nanoparticles (MSNs) hold great potential for theranostics applications because 
of their unique properties, such as hydrophilic surface favoring blood circulation, versatile silane 
chemistry for facile functionalization, biocompatibility, ease of large-scale synthesis and low 
production costs.[1,2] The physical parameters of MSNs have been tuned, as observations in 
biological systems suggest that factors like size, surface charge and shape, can vastly affect 
nonspecific uptake into cells, and furthermore potentially induce cellular responses.[3]  
Particle shape is an important parameter, as it plays an important role in particle interactions 
with cells in vitro,[3-5] and in determining how particles navigate the bloodstream and distribute in 
tissues in vivo.[6-8] When shape is decoupled from volume, charge and material composition, 
mammalian epithelial cells preferentially internalize disc- or rod-shaped hydrogel particles, rather 
than spherical ones.[9] Disc-shaped porous silicon particles accumulate in tumors when injected in 
vivo because of a peculiar tendency to margination toward the blood vessel walls when circulating 
in the bloodstream.[10-11] 
To date, mainly spherical (porous, hollow, multishell and rattle) and rod-shaped MSNs 
particles[3] have been evaluated for their cellular uptake since other morphologies are hard to 
prepare with sufficient control of dispersity. Mesoporous silica nanorods penetrate tumor tissues 
more rapidly than nanospheres, most likely because of improved transport through pores,[12] and 
those with larger aspect ratio (AR) are taken up by cells to a higher extent and with faster 
internalization rates.[13] Moreover, the AR of rod-shaped MSNs was also found to play a role on the 
activation of the micropinocytosis process in cancer cells.[14] The possibility to produce other MSN 
morphologies would lay the basis for gaining better insights into the effect of shape on their cellular 
uptake and drug delivery performance. For example, flat discoidal MSNs may be accepted better by 
certain cellular internalization pathways or possess enhanced EPR effect, as demonstrated for 
hydrogel and silicon disc-shaped particles. Moreover, a flat and homogeneous morphology may 
afford a length and orientation of pores that are beneficial for MSN in implants and surface-
mediated drug delivery devices. 
Here we report the bottom-up synthesis of the Nanodiscs (NDs), flat discoidal mesoporous 
silica nanoparticles, and an initial investigation of their biological applications. This novel material 
is internalized into HeLa cancer cells and performs better, in intracellular drug delivery, than 100 
nm spherical MSNs (MSN100). Furthermore, to challenge NDs in the delivery of their payload both 
intracellularly and extracellularly, these particles were also employed in the preparation of self-
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assembled monolayers (SAMs) for targeted cancer cell adhesion and surface-mediated delivery 
experiments.[15-19] 
2. Results and Discussion 
2.1 Synthesis and characterization of NDs 
The NDs were synthesized using a modified Stöber protocol, employing tetramethyl orthosilicate 
(TMOS) as silica source and octadecyltrimethylammonium chloride (OTACl) as template in a 
water/methanol 60/40 (w/w) mixture and in the presence of NaOH as catalyst (Fig. 1a; see SI, for 
complete synthetic details). Scanning and transmission electron microscopy (SEM and TEM; Fig. 
1b-d; see also Fig. S1-2) of NDs displayed a homogenous flat discoidal morphology, characterized 
by an average diameter and thickness of 507.8 ± 93.8 nm and 80.0 ± 4.0 nm, respectively.  
 
Figure 1: a) Schematic representation of the synthetic procedure for the synthesis of the NDs; b) SEM and c-d) TEM 
images of the NDs. 
Under alkaline conditions and at the surfactant concentration used, the formation of the 
particles occurs through a cooperative self-assembly mechanism, as reported in the literature.[20-22] 
In situ measurements on similar systems suggest in fact that in the initial phase of the process 
silicate anions interact electrostatically with spherical surfactant micelles, leading to the formation 
of silica-surfactant aggregates that grow and assemble as silica polymerization occurs. The resulting 
composite mesostructured material eventually precipitates out of the reaction mixture.[20] 
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It is well known that the synthesis of mesoporous silica is a process extremely sensitive to 
the experimental conditions used and to the specific chemistry and interactions involved in each 
investigated system. The slightest modification of these parameters can lead to the variation of size, 
shape and porosity of the produced particles. It follows that the explanation of the formation of the 
discoidal NDs resides in the reported experimental conditions. Exploratory experiments were thus 
carried out in order to assess the influence of several parameters on the synthesis of NDs (Fig. S3). 
It resulted that the H2O content of the solvent mixture influences significantly the morphology of 
the produced particles.[23,24]  By gradually decreasing the water content in the H2O/MeOH mixed 
solvent from 60/40 to 30/70 (w/w) we observed a gradual shift of the morphology of the product 
from discoidal to spherical (Fig. S3a-d). Specifically, when decreasing the water content to 50/50 
(w/w) we seem to loose some control on the morphology of the product obtaining irregular thinner, 
wider discs compared to the NDs (Fig. S3c). By further decreasing the water content of the mixed 
solvent we obtain first polydisperse and then larger regular spherical particles at 40/60 and 30/70 
(w/w) percentages respectively (Fig. S3a-b). The water content is evidently playing an important 
role in molding the morphology of the NDs, with a higher water fraction of the mixed solvent 
favoring the formation of discoidal particles over spherical ones. 
This central role may be explained by the fact that the water content affects directly: (i) the 
self-assembly of the surfactant; and (ii) the hydrolysis of the silane. Undeniably, a higher content of 
water induces a decrease of the surfactant critical micellar concentration and increase of 
aggregation number (the number of molecules present in a micelle),[25,26] as well as affecting the 
composition of the solvation shell.[26] This is because as the concentration of MeOH decreases the 
alcohol molecules in the solvation cell are replaced by H2O, partially screening the headgroups of 
the surfactant thus promoting the micellar aggregation process. The solubility of the silane, TMOS 
(soluble in organic solvents), is negatively affected by the addition of water to the reaction mixture. 
Yet, at the same time water enhances its hydrolysis rate, prompting a faster condensation of silica. 
These considerations suggest that the discoidal shape of NDs is therefore achieved in experimental 
conditions where a fast condensation of silica occurs on very compact micelles, which form at 
lower concentration and aggregate easily.[27]  
To confirm the importance of the kinetics of condensation of silica in the formation of the 
NDs, we performed a test reaction by lowering the pH of the reaction mixture, another important 
parameter affecting the hydrolysis of the silane. At pH ≈ 10 (≈ 12 for the standard NDs synthetic 
conditions; Fig. S3e) the particles obtained are again less regular, inhomogeneous, brittle discoidal 
particles compared to NDs, characterized by a lower degree of condensation. 
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The preparation of NDs is also very specific for the surfactant employed. Variations in the 
counterion and the length of the aliphatic chain lead to different packing geometries and interactions 
with the silicates, resulting in very different products. For example, when we attempted the 
synthesis of the NDs by replacing the surfactant OTACl with cetyltrimethylammonium bromide 
(CTAB), spherical particles were obtained (Fig. S3f). Since at the used concentration (11.5 mM) 
both the surfactants are expected to form spherical micelles before the addition of TMOS, even 
though slightly bigger for the OTACl, the major role in the formation of discoidal particles may be 
attributed to the counterion that influences the interactions between the micelles and the growing 
silicates. Depending on its binding efficiency, the counterion blocks the adsorption of silicate ions 
onto the micellar surface during the condensation process, and it is known that the binding 
efficiency follows the Hofmeister series, according to which Cl− is one of the least binding.[28-29] It 
follows that Cl−, being the least bound to the micelles most likely favors the occurrence of the 
attractive electrostatic forces between the polysilicates and the surfactant micelles and therefore 
determines a faster growth of the composite material, leading to formation of the NDs, the 
kinetically favored products as supported also by the above mentioned experiments.  
Comprehensive morphological and physicochemical analyses of the NDs were performed to 
fully characterize the particles. SEM and TEM imaging of the NDs (Fig. 1b-d) evidenced the 
consistent discoidal morphology of the material. TEM on calcined NDs also revealed the presence 
of a porous framework in the particles. N2 adsorption analysis of the NDs measured a BET surface 
area of 863 m2/g, total pore volume of 0.83 cm3/g, and an average pore diameter value of 3.8 nm 
(Fig. S4). Further confirmation of the porous structure was provided by the small-angle X-ray 
scattering (SAXS) pattern that presented two broad signals, centered at q = 1.7 and 3.2 nm−1 (Fig. 
S5), consistent with the (100) and (110) planes of hexagonal mesostructures. Even though the broad 
peaks suggest the absence of a long range ordering of pores, the value of the d100 spacing = 3.7 nm 
is in agreement with the pore diameter distribution determined by N2 adsorption analysis. Elemental 
composition of NDs was determined by X-ray photoelectron spectroscopy (XPS; Fig. S6a, and 
Table S1). The particles, as expected, were found to be mainly composed of Si(2p) (28.1 ± 0.7 
atomic percentage [At%]) and O(1s) (63.6 ± 0.3 At%). Thermogravimetric analysis (TGA) only 
exhibited a negligible weight loss (3.1%, Fig. S7) in the investigated temperature range (100-750 
°C), attributable to the condensation of silanol groups. Finally, the recorded ζ-potential of NDs, -
25.9 ± 1.2 mV, in PBS (pH 7.4) confirmed the negative surface charge for these silica nanoparticles 
in physiological conditions (Fig. S8). 
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2.2 Biocompatibility, cellular uptake and biodegradation of NDs 
Once the NDs have been characterized, the investigation of the cellular uptake, cytotoxicity, and 
drug delivery of these particles was tackled as a first evaluation of their possible use for biomedical 
applications. HeLa cells were initially incubated with NDs at two different concentrations, 50 and 
100 µg/mL (Fig. S9), and the viability was evaluated after 3, 24 and 72 hour incubation. Negligible 
cell death was detected indicating very low cytotoxicity of the NDs in the concentration range 
tested.  
The cellular association of NDs was quantified by using flow cytometry analysis (FACS). 
The particles were labeled with Rhodamine B through a post-synthetic grafting (r-NDs, see SI for 
details; Fig. S10) and incubated with HeLa cells at a concentration of 50 and 100 µg/mL, for 3, 24 
and 72 hours. To assess the effect of the discoidal shape on the cellular uptake of MSNs we 
compared r-NDs to Rhodamine B-labeled 100 nm spherical MSNs (r-MSN100, see SI; Fig. S10), 
possessing the same surface charge (Fig. S8). Interestingly, for both the employed concentrations 
the FACS measurements after 3 hours indicated a more efficient association of r-NDs to the 
cancerous cells compared to the r-MSN100 (FACS; Fig. 2a for 50 and S11 for 100 µg/mL). After 24 
and 72 hours of incubation the percentage of positive cells further increased for r-NDs, as up to 
50% of the cell population resulted positively tagged. In contrast, for r-MSN100 the association 
decreased in time becoming negligible after 72 hours.  
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Figure 2: a) FACS analysis of the cellular uptake of r-NDs (50 μg/mL) in HeLa cells upon 3, 24 and 72 h incubation. r-
MSN100 were tested for comparison; b) SEM images of HeLa cells incubated with r-NDs at a concentration of 50 
µg/mL for 3 h, further washed and incubated with fresh medium for 1 h. Scale bar = 10 µM (sx) and 1 µM (dx); c) Z-
stack confocal imaging of the r-NDs after 3 h incubation in HeLa cells. Magenta channel = Rho; green channel = 
Phalloidin Alexa Fluor® 647; blue channel = DAPI. Scale bar = 10 µM; d) Confocal images of r-NDs after 1 h 
incubation in Hela cells for co-localization experiment. Magenta channel = Rho; Yellow channel = LysoTracker®. Scale 
bar = 10 µM; e) DOXO release profile from DOXO@NDs in PBS (pH 7.4; conc. = 0.1 mg/mL); f) cytotoxicity of 
DOXO@NDs when incubated in HeLa at 50 μg/mL for 3, 24 and 72 h. DOXO@MSN100 and DOXO alone were also 
tested as reference, keeping either the dose or the content of DOXO constant; g,h) confocal images of the uptake of 
DOXO@NDs and DOXO after 3 h incubation. Red channel = DOXO. Scale bar = 10 µM. 
To understand whether the r-NDs detected by FACS were only externally bound or rather 
endocytosed by the cancerous cells and define the evolution in time of their localization, we 
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performed SEM investigations and confocal laser scanning microscopy (CLSM) of HeLa cells 
exposed to r-NDs. Specifically, HeLa cells were incubated for 3 hours at 50 µg/mL before washing 
and addition of fresh culture medium (CM). The cells were then further incubated for 1, 24 and 72 
hours to perform SEM and CLSM analysis. 
SEM imaging of the surface of cancer cells (Fig. 2b; see also Fig. S12) showed that 1 hour 
after incubation and CM renewal, few r-NDs clusters are detected on the cell surface. No loose r-
NDs aggregates could be detected in the sample. Interestingly, after 24 and 72 hours (Fig. S12), the 
externally bound NDs could no longer be imaged most probably as a result of a slow uptake 
process, as reported for larger silicon discoidal particles.[30]  
Internalization of r-NDs was confirmed by CLSM. The Z-stack images (Fig. 2c; see also 
Fig. S13) of HeLa cells after 3 hours incubation at 50 µg/mL, recorded after membrane staining 
with Phalloidin Alexa Fluor® 647, clearly demonstrated the presence of r-NDs inside the cancerous 
cells. The subcellular localization of the internalized particles was further investigated by 
employing the lysosome-specific fluorescent marker Lysotracker® Deep-Red (Fig. 2d; see also Fig. 
S14). To obtain an objective evaluation of the labeled vesicles, the fluorescent signals of the r-NDs 
and the stained organelles were quantified using ImageJ software. After 1 hour, 65% of 
Lysotracker-positive vesicles were also labeled with r-NDs (Pearson's correlation coefficient: 
0.652). This indicates that the nanoparticles are internalized via classical endocytosis, as observed 
for both large silicon discoidal particles[30] and MSN100.[31] In agreement with the trend detected by 
FACS, after 24 hours the co-localization increased to 74% (Pearson’s correlation coefficient: 0.743; 
Fig. S14), probably due to further internalization of the aggregates present on the cell surface. After 
72 hours, the co-localization decreased to 53% (Pearson’s correlation coefficient: 0.534; Fig. S14). 
This drift, not related to the lesser association reduction detected by FACS, could either reflect a 
loss of signal from Lysotracker or the partial degradation and escape of the particle debris from the 
lysosomes.  
To confirm the latter hypothesis we investigated the stability of NDs in HeLa cells by 
measuring the concentration of the silicon in the incubation medium by means of inductively 
coupled plasma atomic emission spectrometry (ICP-AES).[32] We performed this analysis because 
once the internalized nanoparticles start to degrade, small silica debris are released in the CM, in 
which no other form of Si is present. Again, HeLa cells were incubated for 3 hours at 50 µg/mL 
before washing, addition of fresh CM and further incubation for 1, 24 and 72 hours, at which time 
points ICP-AES analysis was performed. From the data reported in Table 1 it is clear that Si was 
only detected in the CM of the cancer cells incubated with NDs and not in the CM of cells not 
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incubated with particles used as control. Moreover Si concentration resulted increasing with time, in 
line with the assumption that there is a constant degradation of the internalized particles. In similar 
experimental conditions MSN100 did not present any sign of degradation,[31] possibly indicating an 
influence of the aspect ratio and the highly ordered mesostructure of NDs on their degradation. Yet, 
these preliminary studies do not address such correlation and more investigation will be undertaken 
to elucidate this interesting aspect.  
Table 1. ICP-AES results for the detection of Si in the CM of HeLa cells and HeLa cells previously incubated with 
NDs at 50 µg/mL for 3 h and washed.  
 Si / ppm 
 NDs Control 
1 h 0.15 ± 0.05 -- 
24 h 1.09 ± 0.02 -- 
72 h 1.70 ± 0.10 -- 
 
2.3 Drug delivery performance of NDs 
After establishing that the NDs are biocompatible and efficiently taken up by cancer cells, we 
investigated their activity as drug delivery system. NDs were loaded with the anticancer drug 
Doxorubicin (DOXO; DOXO@NDs, see SI), and the loading established by means of UV-Vis 
spectroscopy (25wt.%, Fig. S15). The release kinetics of the drug from DOXO@NDs in PBS (pH 
7.4) was first evaluated spectroscopically over a 72 hours timespan (Fig. 2e). The drug release 
process is characterized by a burst discharge occurring immediately after incubating the 
DOXO@NDs in PBS, possibly due to superficially adsorbed DOXO molecules and molecules 
close to the channel entrance, followed by a sustained release over the rest of the measurement, 
until complete unloading of the drug. Since the NDs mostly preserved their structural integrity in 
PBS (pH 7.4) when stirred at 37 ˚C up to 7 days (Fig. S16), the release kinetics should be attributed 
mainly to the escape of the drug molecules from the porous structure. Indeed, only partial 
exfoliation and few cracks were detected for NDs under these conditions, as the degradation of 
MSNs is known to decelerate with the size, and most importantly the aspect ratio of the particle.[33] 
HeLa cells were treated with 50 and 100 µg/mL of DOXO@NDs (corresponding to a 
DOXO content of 12.5 and 25 µg/mL; Fig. 2f and S17 for the treatment of HeLa cells with 50 and 
100 µg/mL respectively). After 3, 24 and 72 hour incubation, the cells were washed with PBS and 
their viability measured. Free DOXO, NDs, MSN100 in their pristine form and loaded with DOXO 
(DOXO@MSN100; see SI), all containing the same content of DOXO, were also incubated for 
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comparative purpose. Both NDs and MSN100 did not show significant cytotoxicity at the 
concentrations tested at any of the time points. Similarly to free DOXO, after 3 hours of incubation 
HeLa cells treated with DOXO@NDs suffered a viability decrease to about 90-80% for 50 and 100 
µg/mL respectively. Confocal images recorded after 3 hours incubation of DOXO@NDs in HeLa 
cells at 50 µg/mL (Fig. 2g) already displayed a high concentration of the anticancer drug in the 
nuclei, confirming the easy escape of the drug from the porous framework. Small aggregates 
present on the surface of the cells, and ready to be internalized, are also detected. After 24 and 72 
hours of incubation of DOXO@NDs the cell viability further dropped to 70-50% and after 72 hours 
it dropped to 10%, with an overall cytotoxic effect comparable to that of the free anticancer drug. 
These data not only indicate that NDs grant exhaustive release of their payload, but also confirm the 
very efficient cellular uptake of these particles, as well as their complete biocompatibility. On the 
contrary, DOXO@MSN100 only presented minor cytotoxicity after 3 hours incubation, whilst after 
24 and 72 hours the viability of HeLa cells only decreased to 70-80%, the drug payload being equal.  
The therapeutic activity DOXO@NDs likely derives from a synergistic effect of their 
efficient cellular uptake and their efficiency in releasing the drug from their porous framework. 
NDs preserve the loaded DOXO from degradation and dispersion in the CM and, due to their high 
affinity for the cells, convey all their cargo within the cellular environment where it is free to 
perform its therapeutic activity. Since chemotherapeutic drugs have adverse side effects, drug 
loading in a non-cytotoxic nanocarrier for controlled release is preferred for in vivo applications. 
NDs, granting complete cellular uptake and a gradual yet exhaustive intracellular drug release, 
would confine the cytotoxic activity of the drug thus mitigating its side effects and allowing less 
frequent administrations.  
2.4 Surface-mediated delivery from NDs monolayers 
The advantage of the disc-shaped morphology on the implementation of MSNs based devices was 
demonstrated by preparing a dye-releasing SAM of NDs for cell adhesion experiments and in situ 
staining of the adsorbed live cells (Fig. 3a). Specifically, NDs were loaded with Nile Red (NR; 
NR@NDs, see SI), a hydrophobic dye able to stain the membrane of cells,[34] and the particle 
surface functionalized with (3-aminopropyl)triethoxysilane (APTES; NR@NDs-APTES, see SI), to 
allow for grafting onto a pre-activated glass substrate (see SI).[35] Nile red encapsulation, as well as 
the grafting of the amino-silane on the NR@NDs, were monitored by means of XPS and TGA 
analysis (Fig. S6b-c, and Table S1). The covalent binding of APTES on the surface, NR@NDs-
APTES, was further confirmed by a strong shift of ζ-potential in solution, from the negative 
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unfunctionalized silica to a positive value of the protonated amines (+19.6  0.5 mV; Fig. S8). 
Fluorescence spectroscopy confirmed the presence of the dye in both hybrids (Fig. S18). 
The SAMs were prepared following a procedure previously reported for zeolites.[35] SEM 
images of the monolayers of NDs (Fig. 3b, Fig. S19) highlighted a homogenous particle 
distribution, without significant vertical stacking or tilting of the particles, providing a large flat 
contact area for the adhesion of the cancerous cells. Confocal analysis confirmed persistence of NR 
within the SAMs (Fig. S20) when the monolayers were immersed in water based solutions. To 
favor adhesion of the cancerous cell line, the surface of the monolayer was functionalized with folic 
acid (FA), a HeLa cells specific targeting moiety (FA-SAM, see SI).[36] The bio-coating was 
confirmed by high resolution XPS analysis, which shows the N(1s) and C(1s) signals of FA-SAM, 
at the energy characteristic for amidic bonds between the anchored aminopropylsilane and the FA 
(Fig. S21).[37] 
 
Figure 3: a) Graphical representation of the in situ cellular staining experiment; b) SEM image of the FA-SAM of NDs. 
In the inset an enlarged image of the monolayer; c-d) confocal images of HeLa cells adsorbed on FA-SAM and SAM, 
respectively (blue channel = DAPI); e) cell counting of the HeLa cells adsorbed onto the monolayers; f-h) confocal 2D, 
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2.5 and 3D images of the HeLa cells adsorbed onto FA-SAM, after 24 h adhesion, fixation and staining with DAPI. 
Red channel = NR, blue channel = DAPI. 
With the morphology and the surface functionalization of the SAMs confirmed, adhesion 
experiments were carried out. Control SAMs, without the targeting units, were also prepared and 
used as control. HeLa cells were seeded on FA-SAM and, after 3 and 24 hours of incubation at 37 
°C, the cells were fixed with paraformaldehyde (4 wt.% in PBS) and the nuclei stained with DAPI, 
to allow imaging and counting of the cells at the confocal microscope. As shown in Figures 3c-d 
(see also Fig. S22), the adhesion of cancer cells on the monolayer was increased by the presence of 
FA (7.6 and 10-fold increase for the FA-SAM vs the control, after 3 and 24 hours of incubation, 
respectively; Fig. 3e). Analysis of the NR signal in the FA-SAM sample fixed after 24 hours of 
adhesion confirmed the presence of the dye homogeneously staining the adhered cells, endorsing 
the effective transfer of NR from the substrate to the cells (Fig. 3f-h). As mentioned the NR dye 
cannot escape the pores of the NDs because of its hydrophobicity (no NR release detected in the 
CM, Fig. S23). Therefore the efficient transfer of NR to the cells must be favored by the large flat 
surface area of the NDs, able to maximize the contact with the hydrophobic cell membrane of the 
cells, which provides a suitable environment for the spontaneous diffusion of the NR out of the 
monolayer  
Another important factor enhancing the release activity of this monolayer is the consistent 
directional alignment of the pores of the discs, all perpendicularly oriented in respect to the 
adsorbed cells (not possible for spherical MSNs), allowing for complete exploitation of the loaded 
dye. The release was further monitored over time by live cell confocal microscope imaging (Fig. 
S24). This analysis demonstrated that the diffusion of the dye into the adsorbed cell layer starts 
shortly after the cells adhere, as the NR was already staining the HeLa within the first 3 hours of the 
experiment. The intensity of the emission of the NR in the cells increased with time, indicating a 
continuous diffusion of the dye and an efficient extracellular delivery of the hydrophobic molecules. 
3. Conclusions 
Flat disc-shaped mesoporous silica nanoparticle, obtained via a templated modified Stöber 
condensation process, have been synthesized and fully characterized, widening the range of 
morphologies of MSNs available for the preparation of tailored nanotheranostic agents. The NDs 
resulted able to efficiently deliver their cargo both intracellularly, when internalized in cancerous 
cells, and extracellularly, when part of bioactive surface-mediated drug delivery systems. The 
morphology of these particles boosted cellular uptake, and resulted exceptionally beneficial for 
fostering intimate and effective contact with the cells adsorbed onto the monolayers. In both the 
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intracellular and extracellular delivery application, the width and orientation of the pores of NDs 
maximized the externalization of the payload. Studies aimed at progressing the knowledge on the 
bioactivity of NDs once internalized in the cells and their biodistribution when injected in vivo, as 
well as the design of implantable devices containing the NDs, are currently on going and will 




Supplementary information (SI) available: full experimental procedures, additional SEM and TEM 
images of particles, size distribution, SAXS, N2 adsorption, XPS, TGA, ζ-potential, photophysical 
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